Vanguard

Vanguard Expands Investor Choice Pilot Program, Adds New Funds, Policy Options, and Retirement Plan Participation

VALLEY FORGE, PA — Vanguard has announced a significant expansion of its groundbreaking Investor Choice pilot program, designed to empower individual and institutional investors to actively participate in proxy voting …

Vanguard Expands Investor Choice Pilot Program, Adds New Funds, Policy Options, and Retirement Plan Participation Read More



Ocugen

Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received orphan medicinal product designation from the European Medicines Agency (EMA) for OCU410ST, a promising treatment for ABCA4-associated retinopathies including Stargardt disease, …

Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment Read More